Production (Stage)
Chemomab Therapeutics Ltd.
CMMB
$1.23
$0.032.50%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.84% | -19.75% | -7.43% | -18.70% | -18.02% |
| Total Receivables | -26.10% | 206.23% | -68.66% | 4.72% | 116.78% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.33% | -1.32% | 5.56% | -3.90% | 0.00% |
| Total Current Assets | -20.09% | -19.43% | -6.57% | -17.98% | -19.07% |
|
|
|||||
| Total Current Assets | -20.09% | -19.43% | -6.57% | -17.98% | -19.07% |
| Net Property, Plant & Equipment | -5.95% | -5.61% | 54.79% | -8.62% | -8.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.53% | -7.69% | -7.30% | -6.38% | -5.87% |
| Total Assets | -19.24% | -18.70% | -5.41% | -17.60% | -18.69% |
|
|
|||||
| Total Accounts Payable | 111.20% | 2.13% | -29.41% | 5.86% | 31.34% |
| Total Accrued Expenses | -17.95% | -11.42% | -6.35% | -6.32% | -5.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.91% | 44.74% | -27.62% | -6.09% | -6.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -2.05% | -9.09% | -9.91% | -2.46% | 3.67% |
|
|
|||||
| Total Current Liabilities | -2.05% | -9.09% | -9.91% | -2.46% | 3.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.36% | -11.39% | 6,220.00% | -46.77% | -31.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.54% | -9.24% | -4.11% | -2.85% | 3.20% |
|
|
|||||
| Common Stock & APIC | 0.27% | 0.19% | 1.72% | 1.97% | 0.48% |
| Retained Earnings | -3.92% | -4.36% | -4.79% | -10.98% | -13.72% |
| Treasury Stock & Other | -- | -- | -- | 0.00% | 0.00% |
| Total Common Equity | -25.10% | -21.57% | -5.80% | -21.33% | -22.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.10% | -21.57% | -5.80% | -21.33% | -22.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.10% | -21.57% | -5.80% | -21.33% | -22.83% |
|
|
|||||